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Summary
We analyzed the molecular mechanism for the immunoglobulin (Ig) multiple isotype expression
using a transgenic mouse (TG.SA) model system. Though most of the endogenous p, chain
expression was excluded by the expression of the human rearranged A transgene in the TG.SA
mouse, a significant portion of splenic B lymphocytes could express the transgenic human IgM
and endogenous mouse IgG simultaneously afterstimulation with lipopolysaccharide and interleukin
4. The fluorescence-activated cell sorter®-purified population of the human IgM+/mouse IgG
cells expressed mRNA that consisted of properly spliced sequences of the transgenic VDJ and
the endogenous mouse Cy genes (trans-mRNA), together with the transgenic human p, mRNA
and germline transcripts of the mouse Cy gene, without apparent rearrangement of the trans-
gene. We also found that a lymphoma tumor, derived from the cross between the TG.SA mouse
and another transgenic mouse carrying Ig H chain enhancer-driven c-myc oncogene, expressed
about equal levels of the trans-mRNA and the transgenic p, mRNA without DNA rearrangement
in either the transgene or the endogenous mouse switch region. These findings strongly support
our previous proposal that the trans-splicing can account for the multiple isotype expression in
this transgenic model and also suggest that novel molecular mechanism(s) might be involved
in this reaction.
P
rogeny of a single B lymphocyte can switch the isotype
of the expressed Ig from IgM to IgG or other classes
without changing the variable region sequence that deter-
mines the antigen specificity (1, 2). This phenomenon, named
Ig class switching, is mediated by DNA rearrangement of
the constant region (C) genes of the Ig heavy chain. This
DNA rearrangement, called S-S recombination, takes place
between the S regions located 5' to each C gene, except for
the Cs gene, and brings the VDJ exon to proximity of
the C gene to be expressed by the deletion of the inter-
vening CH gene(s). Recent investigations have shown that
the C gene(s) to be deleted by S-S recombination is excised
out from the chromosome as a circular DNA (3-5). This
finding provides the direct evidence for the intrachromosomal,
looping-out deletion model for S-S recombination (6). These
studies also indicate that 114 can modify the specificity of
the recombination target gene (4, 5).
Although deletion of the C genes by S-S recombination
occurs in myelomas (7, 8), hybridomas (9), and normal spleen
cells (10), the deletion model has faced difficulty in explaining
the observation that a single B lymphocyte can express more
than one isotype simultaneously on the surface (11). From
the experiments showing that sorted B cells (12, 13) or B
cell tumors (14, 15) carrying two isotypes had no rearrange-
ment of the expressed C genes, the involvement of RNA
processing in multiple isotype expression was suggested, and
such multiple isotype-expressing cells were proposed to be
intermediates for class switching (2, 12). The production of
multiple isotypes in a single B cell could be accomplished
by either differential splicing of one continuous transcript
of 200 kb or by intermolecular joining of two shorter tran-
scripts (trans-splicing). Given the fact that specific germline
transcripts were made from the target C gene(s) of S-S
recombination (16-18), we proposed that such transcripts could
be involved in the Ig multiple isotype expression as substrates
(acceptors) for trans-splicing (19-21).
We have tested the trans-splicing model using a human p,
chain transgenic mouse line (TG.SA) as a model system (20,
21) . Despite the integration of the transgene outside of the
mouse H chain loci, splenic B cells from TG.SA mice could
synthesize a trans-mRNA that was generated by splicing the
transgenic human VDJ exon sequence properly to the C,
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trans-mRNA synthesiscouldbe dueto either S-S recombina-
tion between the transgene and the endogenous C y1 gene
or trans-splicing between their transcripts, but could not be
accomplished by differential splicing of one contiguous tran-
script (20, 21) .
To exclude that trans-mRNA was produced by inter-
chromosomal S-Srecombination, we have tested whetherS-S
recombination took place in thesortedBcells expressing trans-
genichuman IgM and endogenous mouse IgGand a TG.SA
derived lymphoma tumor expressing the trans-mRNA. We
found that these cells are expressing trans-mRNA without
DNArearrangement . Ourdata strongly suggest that the trans-
mRNA is synthesized by the trans-splicing mechanism and
that this mechanism may be involved in multiple isotype ex-
pression in B cells.
Materials and Methods
Transgenic Mouseand CellsDerivedfrom it.
￿
The transgenic mouse
line (TG.SA) carries a rearranged human VDJ-C gene that
allows expression of themembrane-boundA . chain alone (22) . Pre-
(no. 210) and pro- (no . 216)B cell lymphomas arose spontaneously
by crossing the TG.SA line with another transgenic mouse car-
rying the Ig H chain enhancer-driven c-myc oncogene (23). The
transgenic humanW mRNA was expressed in both tumors but
the trans-mRNA wasexpressed in onlyno. 216 tumor. Hybridoma
2D9, which expressedendogenous mousey2 transcript, wasmade
by fusion between the spleen cell from TG.SA and the Ig-non-
producing myeloma NSl . TG.SA animals were maintained by
crossing with FVB/N mice (Taconic Farms, Germantown, NY),
or with C57BL/6 mice (SIC, Hamamatsu, Japan) .The first gener-
ation of theanimals crossed with C57BL/6 mouse were used for
the sorting experiments .
Spleen Cell Culture Flow Cytometry, andSorting .
￿
Spleen cells from
the TG.SAline were prepared and cultured 3 d in 5% C02-95%
air at 37°C as described previously (20, 21). Fluorescence staining
of surface Igs (20, 21) and brief acid treatment that dissociates Igs
associated through Fc receptors (24, 25) were done as described .
Stained cells were analyzed by flow cytometry on FACScana and
FACStar®, and human IgM*/mouse IgG* cellswere sorted using
FACStar® by a Consort 30 program (Becton Dickinson& Co .,
Mountain View, CA). FITC-labeled anti-human uchain antibody
and R-PE-labeled anti-mouse y chain antibody of goat were ob-
tained from Southern Biotechnologies (Birmingham, AL) .
I-blymerase Chain Reaction .
￿
CytoplasmicRNAfrom the sorted
cellswas extracted using ribonucleoside-vanadyl complex(New En-
glandBio Labs, Beverly, MA) as an RNase inhibitor (26), andDNA
from the same cells was extracted from the nuclear pellet at the
same time . Total cellularRNAs from tumors andhybridomas were
extracted by theguanidium isothiocyanate method (27) . mRNAs
were converted to cDNAs using oligo(dT),2-,s primer andAMV
reverse transcriptase (Seikagaku Kogyo, Tokyo, Japan; and Boeh-
ringer Mannheim Biochemicals, Indianapolis, IN) (20, 21) . Kits
forcDNA synthesis were purchased from Boehringer Mannheim
Biochemicals and Amersham Japan (Tokyo, Japan). PCRwas per-
formed as described (20, 21, 28) using synthesized oligonucleo-
tides as primers . Amplification was done by 50 cycles using an au-
tomatedDNAthermal cycler and TaqDNApolymerase (AmpliTaq;
Perkin-Elmer/Cetus, Norwalk, CT). Primers for PCR were syn-
thesized using automatedDNA synthesizers (models 380A, Band
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381A; Applied Biosystems, Inc., Foster City, CA). Positions of
primers were as follows. Transgenic human V primer 1 (ab-
breviated as tV in figures), 24 met from 356 bases upstream to
the end of the J6 in theV sequence, sense strand (20, 21, 29);
transgenic human Vprimer 2 (tV2), 21 met from 332 bases up-
stream to the end of the J6 in the V sequence, sense strand (20,
21, 29); human C,, primer (hW), 31 met from position 31 to 1 of
theC, exon, antisense strand (30) ; mouse C,., primer 1 (my), 21
metfrom position 41 to 21 of theC, exon, antisense strand (30);
mouse C, ., primer 2 (myl-2, 21 mer from position 251 to 231 of
theC, exon, antisense strand (30) ; mouse I,., primer (mlyl), 21
met from 186 base upstream of the end of the I,., exon (31) ;
humanc-mycexon 1 primer (ml), 21 metfrom 412 bases upstream
of the endof the 1st exon of the human c-myc gene, sense strand
(32) ; human c-myc exon 2primer (m2), 21 metfrom 55 basesdown-
stream of the beginning of the second exon of the human c-myc
gene, antisense strand (32) . Analyses of amplified fragments by
agarose gel electrophoresis andnucleotide sequencing by dideoxy
chain termination method (33) were done as described before
(20, 21) .
Other Molecular Biological Analyses.
￿
Southern blot hybridiza-
tion wasdone as described (34) using probes that were labeled with
12pby random hexamer priming method (35). Filters were washed
at 65°C in0.3x SSC-0.1% SDS in Fig. 4 or in 0.1x SSC-0.1%a
SDS in Fig . 6 . The 1.0-kb SphI-HindIII fragment (36, 37 ; probe
in a Fig . 2) of the human IgH chain enhancer (human enhancer
fragment 1), the 1.4-kb fragment staring from 200 by upstream
to the Bg1II site (36, 37 ; probe b in Fig . 2) of the human Ig H
chain enhancer (human enhancer fragment 2), a human w chain
cDNA clone (19 ; probec in Fig. 2), the 10-kbEcoRI-HindIII frag-
ment of mouse S,., region (38, 39), and the 6.6-kb EcoRI frag-
ment of mouse S.yz region crosshybridizing with S,.2, region under
stringent washing condition (39, 40) were used as probes to detect
switch recombination . The 0.5-kb HindIII-BamHI fragment of
Evi-2 (41 ; unique copy) andthe0.6-kbpromoter region fragment
upstream to theBamHI site ofthe ribosomalRNAgene (42; .mul-
tiple copy) were used for calibration ofDNA amounts . Autoradio-
gramsofDNAblotsfrom the sorted samples were taken and ana-
lyzed using a Bio-image analyzer (BAS2000 ; Fuji Film, Tokyo,
Japan) . RNase protection assay was carried out as described previ-
ously (43) . Hybrids were digested with mixture of RNasesA(0 .1
mg/ml), TI (100 U/ml), and T2 (10 U/ml) at 37°C for 40 min,
and then run on 6% polyacrylamide gel containing 7M urea .
a-["P]-Labeled UTP and dCTP were purchased from New En-
gland Nuclear (Boston,MA)andAmershamJapan (Tokyo, Japan) .
Restriction endonucleases, T7 RNApolymerase, andKlenow frag-
ment ofDNA polymerase I were purchased from Takara (Kyoto,
Japan) and New England Bio Labs, and used according to their
instructions .
Results
Purification ofHuman IgM+/MouseIgG+ Cellsfrom Stimu-
lated Spleen Cells of. the Transgenic Mouse TG.SA . As we
reported previously (20, 21), a significant portion (3-8%)
ofthespleen cellsfrom theTG.SA transgenic mouseexpressed
transgenic human IgMandthe endogenous mouseIgGsimul-
taneouslyon their surface after a 3-4d culturewith LPS and
ILA(Fig. 1A),although expression of theendogenous mouse
Pchainwas almost completely excluded (20-22) . To exclude
the possibility that these Ig moleculeson the cell surfacewere
synthesizedby some other cells, andcytophilically associatedA0
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Figure 1 .
￿
Detection of the human IgM*/mouse IgG* double-positive
cellsinTG.SA spleen cells culturedwith LPS and IL4, and theirpurification
by sorting. (A) Detection ofdouble-positive cells . Spleen cells fromTG.SA
were cultured 3 d with LPS and IL4, stained with FITC-labeled goat
anti-human ,u and PE-labeled goat anti-mouse -y, and analyzed byFACStar®
during the sorting. 5 x 1(N live cells were analyzed . The percentage of
each quadrant is indicated at each corner and that of the target population
is indicated at the top . (B) Purity of the sorted double-positive cells . The
sorted cells were re-analyzed on FACRar® by the same setting as in A .
5 x 103 cells were analyzed. (C) Brief acid treatment to dissociate Igs
bound to the cell surface through Fc receptors . TG.SA spleen cells were
cultured as in A, and treated 1 min with pH 4.0 buffer before staining.
The cells were stained simultaneously with anti-human A (FITC) and
anti-mouse .y (PE), and analyzed on FACScan®. Staining profiles for
anti-human u and anti-mouse ti were separately shown at the left and
right, respectively. 104 live cells were analyzed . Broken, solid, and dotted
lines indicate unstained control, staining without acid treatment, and
staining after acid treatment, respectively.
through Fc receptors, the cells were treated briefly with acid
to dissociate the interactions between Igs and Fc receptors.
The staining profile of acid-treated cells was almost identical
to that of untreated cells (Fig. 1 C), indicating that almost
all Ig molecules detected on their surface were synthesized
de novo. Their de novo syntheses were further confirmed by
detection ofmRNAs (see below) . For further characteriza-
tion of these human IgM+/mouse IgG+ cells at molecular
level, we purified them by cell sorting . Starting from N2 x
107 TG.SA spleen cells cultured for 3 d with LPS and 114,
we obtained N3 x 105 human IgM+/mouse IgG+ cells .
The purity of the sorted cells was >90% as assessed by ob-
servation under a fluorescence microscope (92 of 100 cells
observed were positive for both isotypes) and re-analysis using
FAGS® (Fig. 1 B) .
Expression of trans-mRNA andAbsence of Transgene Rear-
rangement in the Sorted Human IgM+/Mouse IgG+ Cells. To
confirm the expression oftrans-mRNA consisting ofhuman
VDJ and murine mouse Cr sequences in the sorted human
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IgM+/mouse IgG+ cells, we took the PCR strategy as sche-
matically illustrated in Fig. 2. By each combination of the
primers indicated, we detected a clear band of the expected
size for the transgenic human p . mRNA, the trans-mRNA,
and the germline Cy1 transcript (Fig. 3) . From semiquan-
titative experiments by decreasing theamount ofcDNA sub-
jected to PCR, we could estimate that each human IgM+/
mouse IgG+ cell contains >100 and >10 molecules on av-
erage of the transgene mRNA and the trans-mRNA, respec-
tively (data not shown) . These results strongly support the
fact that the human k, chain and the chimeric y chain were
synthesized de novo by the human IgM+/mouse IgG+ cells.
TheTG.SA mice carried two copies ofthe rearrangedhuman
W chain gene as the transgene at a single locus on a chromo-
some different from number 12 where the endogenous Ig
H chain locus is located . To test whether the trans-mRNA
was produced by interchromosomal S-S recombination be-
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￿
Schematic representation ofthe strategy to detect trans-mRNA
by PCR and switch recombination of the transgene by Southern blot .
Structures of the rearranged human P transgene with only relevant re-
striction sites, the endogenous mouse Cti1 gene, a part of the transgenic
,u chainmRNA, a part oftheexpectedtrans-mRNA, and a part ofprocessed
(spliced) form of the germline transcript of the Cy 1 gene are schemati-
cally shown. Exons are indicated as boxes with different shading to distin-
guish functional regions. Enhancer and S regions are shown by circle and
ellipses, respectively. A parenthesis in the transgenes indicates the deletion
of the poly(A) addition site for the secretory u chain. Positions ofPCR
primers are indicated by small arrows with abbreviated names, and ex-
pected sizes to be detectedbyPCR amplifications are shown above (trans-
genic 1) and below (trans-mRNA and germline transcript) the structures
of the transcripts. Two expected sizes are given for different transgenic
primers used (see details in Materials and Methods and Figs . 3 and 5) .
Positions ofthe probes used for the Southern blot are shownby solid arrows
under the structure ofthe transgene, and sizes ofthe restriction fragments
to be detected from the transgenewithout switch rearrangement are indi-
cated with broken arrows.Figure 3 .
￿
Detection of mRNAs in the sorted human IgM*/mouse
IgG* double bearers . Cytoplasmic crude RNAs from the sorted cells was
converted to cDNA by reverse transcriptase . cDNAs equivalent to 5 ng
RNAwere subjected toPCR amplification for transgenemRNA and trans-
mRNA detection, and 2.5 ng RNA-equivalent cDNA was used fordetec-
tion of germline transcript . The products were analyzed by agarose gel
electrophoresis. Primer combinations are shown above each lane. Bluescribe
M13(+)DNA digested with Hinfl was run at the right-most lane as size
markers . Sizes of amplified fragments are shown by arrows .
tween the transgene and the endogenous C.y gene, we ana-
lyzed the transgene configuration in the sorted human
IgM+/mouse IgG* cell population by Southern blot hy-
bridization . At first a careful estimation of the relative amount
ofDNA from the sorted cells against the germline control
DNA (liver or tail) was done either by ethidium bromide
staining (Fig. 4A) or by hybridization of the same filter with
unrelated probes (Fig. 4 B) . Ifthe majority of the sorted cells
underwent S-S recombination in one of the two copies of
the transgene, the intensity ofthe transgeneband in the double-
positive cells should decrease to about halfofthat of the germ-
line control, and the rearranged bands should migrate as a
smear because ofthe heterogeneity of switch recombination
sites . The relative intensities of the fragments (9.0-kb Hin-
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dIII and 5.5-kb EcoRI+BamHI) encompassing the switch
region of the transgene in the double-positive cells were al-
most equal to and more than 90% of those in the germline
control DNA by densitometric analyses of the blots . The
results indicate that the majority of human IgM* /mouse
IgG+ cells did not undergo S-S recombination, and the
simultaneous expression of transgenichuman p, and chimeric
mouse -y chains is best explained by the traps-splicing mecha-
nism. It should be noted, however, that the conclusion based
on the above results is limited because sorted IgM+/IgG+
cells may not be completely pure, and rearranged transgene,
if any, in such heterogenous B cells cannot be detected as
discrete bands .
Lymphomafrom the 'IG.SA LineExpressedthe traps-mRNA
without S-S Recombination . To overcome the limitations of
the above experiments, we looked for TG.SA-derived mono-
clonal B cell lines and tumors that express the traps-mRNA .
The probe used for RNase protection assay should give rise
to a 397-base protected band for the traps-mRNA between
transgenic human V.DJ. and endogenous mouse Cy (Cyt,
Cy26, and Cy&) genes, and a 356-base band for transgene
products, because these C., genes have only a few discon-
tinuous point mutations in the 5' 41 bases (Fig. 5 A, left) .
12 lymphomas derived from transgenic crosses between a lym-
phoma prone strain and a human IgM-carrying strain were
screened (23) . One, no. 216, a solitary pro-B cell lymphoma,
that was negative for surface IgM but positive for the
Ly5/B220 antigen and had no Ig gene rearrangements con-
tained almost equal amounts of the traps-mRNA and trans-
genemRNA even under a stringent condition for theRNase
treatment (Fig. 5 A) . Under this RNase treatment condi-
tion using RNases A, Tl, and T2, no artificially protected
bands were observed in a mixture of human w and mouse
y transcripts (Fig. 5 A) .
To confirm that the 397-base protected product is due to
the properly spliced traps-mRNA, we carried out the PCR
experiment using the same primer combination as in our
previous report (20, 21) . The 3' primer for the traps-mRNA
Figure 4.
￿
Absence of interchromo-
somal switch recombination in the
sorted doublebearers. Indicated amounts
ofDNA from the sortedcells and liver
DNA from the same line (A) or tail
DNA from the same animal (B) were
digested with HindIII (A) or EcoRI
plus BamHI (B) and subjected to elec-
trophoresis in 0.6% agarose gel and
transferred on to nylon (A) ornitrocel-
lulose (B) filters. The filters were hy-
bridized with human it chain cDNA
(probe c in Fig. 2) in A, or a mixture
of the human enhancer fragment 1
(probe a in Fig. 2) and Evi-2 fragment
in B. The filter used in B was re-
hybridized with ribosomal RNA gene
probe to confirm the DNA amount,
and the result is shown below B . Sizes
of the detected bands are shown by
arrows .1389
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Figure 5 .
￿
Characterization ofturns-mRNA
expressed in a pro-B cell tumor derived from
theTG.SA line . (A) Detection ofturns-mRNA
by RNase protection assay. 10 pg eachoftotal
RNA from HeLa cell transfected by SV40-
driven human p (lane 1), hybridoma 2D9 ex-
pressing y2 transcript (lane2), the mixture of
theformertwoRNAs (lane 3), tumorno. 210
(lane 4), and tumor no . 216 (lane 5) were hy-
bridized with turns-mRNA probe as shown at
right . The small protected fragments (41 bases)
expected from y chain transcripts (lanes 2, 3,
and 5) were not detected in this hybridization
and digestion condition . Sizes ofprotected frag-
ments and their origins are shown . (B)
Specificityofsplicing combination checked by
PCR . cDNA of tumor no. 216 and cloned
cDNAs ofturns-mRNA (puy) and transgenic
A mRNA (pp) were subjected to PCR using
primer combinations indicated above the gel.
Ladders ofmultiples of123-bp fragments were
run as size markers at both sides . The expected
sizes for thePCR products were: tVhp, 387
bp; tVmy, 397 bp ; ml-m2, 467 bp; ml-hp,
443 bp ; tVm2, 411 bp. Bands visiblein tVm2
lane of no. 216 cDNA and tVhp lane of pAy
were ofwrong sizes. (C) Sequence analysis of
PCRamplified cDNA of turns-mRNA. The
PCRamplified fragment from tumor no. 216
cDNA using tVmy primer combination was
subcloned and sequenced . Sequence ladders of
the antisense strand at theJ-C exon junction
are shown with the read sequence of the sense
strand at the left side . Exonal regions and their
junction are also indicated .
detection could amplify Cy t, Cy2b, and Cy2, mRNAs be-
cause it was complementary to the mouse Cyi sequence with
only one base difference from the Cy2b and Cy 2, sequences.
DNA fragments of expected sizes for the transgenicmRNA
and the trans-mRNA were amplified from tumor no. 216
cDNA (Fig. 5 B) . Specificity of the primers was confirmed
by amplification of previously cloned cDNAs of transgenic
itmRNA and trans-mRNA . The transgenic V primer and
mouse Cy primer combination gave no band from transgene
cDNA clone (Fig . 5 B) . Since no amplified bands were de-
Figure 6 .
￿
Absence of interchromosomal switch recombination of the
transgenic and endogenous switch regions in tumor no. 216 . DNAs from
hybridoma 2139, its fused myeloma NS 1, FVB/N mouse liver, tail ofTG.SA
line, and tumors nos. 210 and 216 were digested with Xbal (A and B),
BamHI (C), or HindlII (D), and separated by agarose gel electrophoresis
followed by transfer to nitrocellulose filters. Filters were hybridized with
mouse S tir (A), mouse Sy2b (B), or human enhancer 2 (probe b in Fig.
2 ; C and D) probes. There were RFLPs in S . yl and Sy2 regions among
FVB/N and CDl outbred mice in which the TG.SA line was established
and maintained at an earlier stage . 2139 hybridoma was made from the
TG.SA animal maintained in FVB/N background, therefore, the control
should be FVB/N liver and the fusion partner NS 1 DNAs . Control for
tumor no. 216, which arose from the animal of CDl background should
be tumor no . 210, which arose from a sibling outbred animal and did not
express the turns-mRNA .tected by combination of transgenic V and c-myc oncogene
primers, or c-myc oncogene and transgenic CN primers, in
spiteof the presence of abundant c-myc mRNA in this tumor,
combination of the exon sequences spliced in trans-mRNA
was specific. Amplified cDNA of the trans-mRNAfrom tumor
no. 216 was subcloned and sequenced. As shown in Fig. 5
C, the transgenic VDJ exon sequence was properly spliced
to the first exon sequence of the mouse Cy2a gene. This se-
quence data unequivocally demonstrate that the tumor no.
216 expressed the properly spliced trans-mRNA ofthe trans-
genic VHDJH and endogenous mouse Cy2, regions, and also
exclude the contamination of previously cloned cDNA (V.
Cyl) because we have never constructed artificial trans-mRNA
or cDNA of the y2a isotype.
Monoclonal DNA rearrangement in the no. 216 lymphoma
should be easily detected. We have analyzed rearrangement
of the endogenous S regions for the Cyl, Cy2b, and Cy2a
genes and the transgene by Southern blot hybridization using
mouse Sy 1 (Fig. 6 A), Sy2b (crosshybridized with Sy2a) (Fig.
6 B), and human Ig H chain enhancer regions (Fig. 6, C
and D) as probes. None of these probes detected monoclonal
rearrangement of the transgene and the Cy genes. The rela-
tive band intensities of these genes remained unchanged, ex-
cluding polyclonal rearrangement as well. These results
strongly suggest that no. 216 tumor cellsexpressed the trans-
mRNA without S-S recombination and support the fact
that trans-splicing is a likely mechanism for generation of
trans-mRNA.
Discussion
We have shown that the trans-mRNA containing the trans-
genic human V region and the endogenous Cy sequences are
expressed in lymphoma cells as well as double-positive sorted
spleen cells derived from the TG.SA transgenic mice. These
cells did not show any sign of S-S recombination. The results
support the hypothesis that trans-splicing is responsible for
generation of trans-mRNA. Synthesis of trans-mRNA does
not seem to be dependent on either the specific insertion site
of the transgene or the specific V or C region sequence of
the transgene, because we coulddetect trans-mRNA in simi-
larlystimulated spleen cells of another transgenic mouse line
that carried a rearranged mouse VDJCp gene (H. Han,
A. Shimizu, and T Honjo, unpublished results). We could
not exclude a formal possibility that S-S rearrangement took
place in a small portion of the sorted and tumor cells, and
all the trans-mRNAs were produced by that portion of cells.
However, this possibility seems very unlikely because most
of the sorted cellscarried human IgM and mouse IgG simul-
taneously on their surface and expressed the trans-mRNA to-
gether with transgenic human tt mRNA and sterile Cy1
transcripts, and the expression level of trans-mRNA in the
lymphoma tumor was almost equal to that of the transgene
transcript.
Obviously, our results do not exclude interchromosomal
S-S recombination per se. In fact, other investigators sug-
gested S-S recombination between transgenic p. and endoge-
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nous y genes (44, 45). However, their cases differ from ours
in that their transgenic mice contain a high-copy number
of the murine it gene as the transgene, and trans-expression
was induced by specific antigen (arsenate) stimulation (44,
45) . Because of the extensive homology between the endog-
enous loci and high-copy transgene, homologous recombi-
nation rather than S-S recombination might occur and a rare
recombinational product couldhave been selected by antigen
stimulation and during the hybridoma selection. The TG.SA
transgene is shown to be integrated outside of the endoge-
nous Ig H chain loci by breeding experiments (21). We have
confirmed this by analyzing a hybridoma (2D9) that lacks
the transgene but still retains the endogenous H chain locus
of the TG.SA mouse (Fig. 6) .
Discontinuous synthesis of mRNA is a feature ofmRNA
metabolism in several lower organisms (46), but has not been
demonstrated in intact higher eukaryotic cells. The two well-
characterized modes of discontinuous transcription are RNA-
mediated priming or cap transfer (46) and trans-splicing
(46-56). The former is known to occur in several viral systems,
but this mechanism is probably not involved in the Ig trans-
mRNA synthesis becausejoining at a splicing site like trans-
mRNA does not occur by this mechanism and the trans-
genic human sequence has only partial homology with its
murine counter part. On the other hand, trans-splicing was
demonstrated in several lowereukaryotes (46-51), plant chlo-
roplasts (52-54), and nuclear extracts of HeLa cell (55, 56).
Although trans-splicing is a most likely and reasonable mecha-
nism to generate the trans-mRNA, the following three unique
features of the splicing donor make the present Ig trans-mRNA
synthesis unprecedented. First, only specific pairs of transcripts
are trans-spliced. No other trans-splicing systems require a
specific splicing donor except for the self-catalyzed type in
chloroplasts (57) . Second, the Ig, the donor sequence of the
trans-splicing, has a intron to be cis-spliced as the V region
gene is composed of two exons. Third, the donor is part of
intact transcription unit and thus processed by both cis- (for
the p, mRNA) and trans- (for the second isotype mRNA)
splicing. Therefore, novel molecular mechanism(s) should be
involved in the Ig trans-mRNA synthesis by trans-splicing
to determine the joining specificity of donor and acceptor
combination, and to regulate the occurrenceofcis- and trans-
reactions at the same time. It should be of interest to see if
such a mechanism(s) is confined in the immune system.
In so much as trans-splicing takes place in transgenic B cells
stimulated with LPS and IL4, it is reasonable to assume that
the trans-splicing accounts for the Ig multiple isotype expres-
sion in B cells (12-15). This trans-splicing model is consis-
tent with observations that the germline transcripts from
specific C genes are expressed in association with class
switching (16-19) and that Fl rabbits express significant
levels of V and CH allotypic markers with trans-combination
on membrane-bound and secreted Ig molecules (58-60).
Until now, the immunological significance of the cellsthat
express multiple Ig isotypes has not been well established.
One interesting possibility is that they might be intermediates
for the class switching (2). Our data shown here would sup-
port this possibility because the second expressed isotype bytrans-splicing should correlate with the isotype of the germ-
line transcripts and thus target specificity of S-S recombina-
tion. One of the most attractive yet speculative possibilities
is that the second Ig isotype molecules expressed on the cell
surface might produce a positive or negative feedback signal
for S-S recombination by themselves or through the recogni-
tion and production of mediators by other type ofcells. Thus,
the B cell might be able to express the most suitable isotype
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